HOOKIPA Pharma Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
HOOKIPA Pharma Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q3 2024.
  • HOOKIPA Pharma Inc. Debt-to-equity for the quarter ending September 30, 2024 was 53.9 %, a 28.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 53.9 -21.2 -28.2% Sep 30, 2024
Q2 2024 58.8 -5.46 -8.5% Jun 30, 2024
Q1 2024 64.9 +12.5 +23.8% Mar 31, 2024
Q4 2023 78.5 +39.3 +100% Dec 31, 2023
Q3 2023 75.1 +41.4 +123% Sep 30, 2023
Q2 2023 64.3 +31 +93.5% Jun 30, 2023
Q1 2023 52.4 +18.8 +55.8% Mar 31, 2023
Q4 2022 39.2 +8.83 +29.1% Dec 31, 2022
Q3 2022 33.7 +8.06 +31.4% Sep 30, 2022
Q2 2022 33.2 +7.75 +30.5% Jun 30, 2022
Q1 2022 33.6 +9.24 +37.9% Mar 31, 2022
Q4 2021 30.3 +4.94 +19.5% Dec 31, 2021
Q3 2021 25.6 -0.68 -2.59% Sep 30, 2021
Q2 2021 25.5 +1.69 +7.11% Jun 30, 2021
Q1 2021 24.4 +1.63 +7.17% Mar 31, 2021
Q4 2020 25.4 -11.5 -31.1% Dec 31, 2020
Q3 2020 26.3 -59.1 -69.2% Sep 30, 2020
Q2 2020 23.8 Jun 30, 2020
Q1 2020 22.8 Mar 31, 2020
Q4 2019 36.9 Dec 31, 2019
Q3 2019 85.4 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.